Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Loncar Cancer Immunotherapy ETF | CNCR | Nov 26, 2024 | 13.82 | +0.18 |
Long-Term Bond Index ETF Vanguard | BLV | Nov 26, 2024 | 71.55 | -0.31 |
Long-Term Corp Bond Idx ETF Vanguard | VCLT | Nov 26, 2024 | 77.92 | -0.38 |
Long-Term Govt Bond Idx ETF Vanguard | VGLT | Nov 26, 2024 | 58.12 | -0.33 |
Longboard Pharmaceuticals | LBPH | Nov 26, 2024 | 59.95 | +0.07 |
Longeveron | LGVN | Nov 26, 2024 | 2.00 | +2.04 |
Loop Industries | LOOP | Nov 26, 2024 | 1.41 | -2.08 |
Lottery.com | LTRY | Nov 26, 2024 | 0.32 | -5.21 |
Lotus Technology | LOT | Nov 26, 2024 | 4.19 | -0.24 |
Louisiana-Pacific | LPX | Nov 26, 2024 | 118.96 | -1.05 |
Lovesac | LOVE | Nov 26, 2024 | 37.10 | -3.56 |
Lowes | LOW | Nov 26, 2024 | 274.47 | -0.31 |
LPL Financial | LPLA | Nov 26, 2024 | 327.35 | +0.69 |
LQR House | LQR | Nov 26, 2024 | 0.98 | -18.33 |
LSB Industries | LXU | Nov 26, 2024 | 8.73 | -2.35 |
LSI Industries | LYTS | Nov 26, 2024 | 20.59 | -0.77 |
Ltc Properties | LTC | Nov 26, 2024 | 38.91 | +1.25 |
Lucas GC | LGCL | Nov 26, 2024 | 0.76 | -32.65 |
Lucid Diagnostics | LUCD | Nov 26, 2024 | 1.00 | +1.84 |
Lucid Group | LCID | Nov 26, 2024 | 2.13 | -1.61 |
Lufax ADR | LU | Nov 26, 2024 | 2.30 | -1.29 |
Lululemon Athletica | LULU | Nov 26, 2024 | 318.84 | -2.41 |
Lulus Fashion Lounge | LVLU | Nov 26, 2024 | 1.23 | -2.38 |
Lumen Technologies | LUMN | Nov 26, 2024 | 7.65 | -1.67 |
Lument Finance Trust | LFT | Nov 26, 2024 | 2.58 | -0.39 |
Lument Finance Trust A Pref | LFT-A | Nov 26, 2024 | 22.65 | -2.33 |
Lumentum | LITE | Nov 26, 2024 | 86.98 | -0.25 |
Luminar Technologies A | LAZR | Nov 26, 2024 | 8.69 | -9.48 |
Lumos Pharma | LUMO | Nov 26, 2024 | 4.32 | +0.47 |
Luna Innovations | LUNA | Nov 26, 2024 | 1.82 | -3.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.